A Case Report: Utilization of Topical Amphotericin in Postoperative Mucormycosis

Description Mucormycosis is a rare devastating fungal infection with a high mortality rate often associated with diabetic and immunosuppressed individuals. However, infections found in postoperative states and in immunocompetent patients are rare. Systemic liposomal amphotericin is viewed as a first...

Full description

Saved in:
Bibliographic Details
Published in:HCA healthcare journal of medicine (Print) 2021-06, Vol.2 (3), p.187-189
Main Authors: Wang, Kenny, Jacinto, Jomel, Davis, Alexander, Hetman, Andrei, Kumar, Alok
Format: Article
Language:English
Subjects:
Case Report
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Description Mucormycosis is a rare devastating fungal infection with a high mortality rate often associated with diabetic and immunosuppressed individuals. However, infections found in postoperative states and in immunocompetent patients are rare. Systemic liposomal amphotericin is viewed as a first line treatment for mucormycosis in addition to aggressive debridement to prevent the spread of infection. Literature describing the treatment of mucormycosis with both systemic and topical amphotericin B is scarce. We present a case of an immunocompetent male admitted for perforated diverticulitis who received a left hemicolectomy with colostomy creation. During hospitalization, stool from the colostomy bag was reportedly leaking into the wound. The patient was found to have extensive necrotic tissue with mold growing in his postoperative incision site. The wound culture and pathology report confirmed mucormycosis. The patient was treated with intravenous (IV) liposomal amphotericin B, wound dressings with an amphotericin/saline mixture twice daily and serial wound debridements. The patient was discharged in stable condition with successful wound healing.
ISSN:2689-0216
2690-3830
2689-0216
DOI:10.36518/2689-0216.1191